The first companies to receive the indicative outcome of their requests for relief from next April's 'catch-up' statutory price reductions have until today to submit additional information if they want a revision. …
Companies start submitting additional information in support of 'relief'
October 25, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
AstraZeneca confirms pricing the issue, and acts to create a patient access program
June 16, 2026 - - Latest News -
When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution
June 16, 2026 - - Latest News -
Entropy Neurodynamics clears safety hurdle for IV psilocin trial in binge eating disorder
June 15, 2026 - - Australian Biotech -
Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment
June 15, 2026 - - Australian Biotech -
The 'Dispatched' Week in Review'- 14 June
June 15, 2026 - - Podcast -
Approach policy and pricing negotiations like planning for a product launch
June 15, 2026 - - Latest News -
High Court to decide on patent‑term extensions for formulations as GBMA intervenes
June 15, 2026 - - Latest News